|
US6001968A
(en)
*
|
1994-08-17 |
1999-12-14 |
The Rockefeller University |
OB polypeptides, modified forms and compositions
|
|
DK0877803T3
(da)
*
|
1996-01-04 |
2005-09-19 |
Amgen Inc |
OB-proteinreceptor og relaterede sammensætninger og fremgangsmåder
|
|
US20050019325A1
(en)
|
1996-01-08 |
2005-01-27 |
Carter Paul J. |
WSX receptor agonist antibodies
|
|
US7074397B1
(en)
|
1996-01-08 |
2006-07-11 |
Genentech, Inc. |
Method for enhancing proliferation or differentiation of a cell using ob protein
|
|
US6541604B1
(en)
|
1996-01-08 |
2003-04-01 |
Genentech, Inc. |
Leptin receptor having a WSX motif
|
|
IL120733A0
(en)
*
|
1997-04-29 |
1997-08-14 |
Yeda Res & Dev |
Leptin as an inhibitor of cell proliferation
|
|
FR2767136B1
(fr)
*
|
1997-08-06 |
2004-08-27 |
Genset Sa |
Recepteur complexe lsr, activite, clonage, et applications au diagnostic, a la prevention et/ou au traitement de l'obesite et des risques ou complications associes
|
|
FR2767135B1
(fr)
|
1997-08-06 |
2002-07-12 |
Genset Sa |
Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
|
|
AU4672199A
(en)
*
|
1998-05-20 |
1999-12-06 |
Yale University |
Modulation of angiogenesis and wound healing
|
|
US7208572B2
(en)
|
1998-08-21 |
2007-04-24 |
Albany Medical College |
Leptin-related peptides
|
|
US6777388B1
(en)
|
1998-08-21 |
2004-08-17 |
Clf Medical Technology Acceleration Program, Inc. |
Leptin-related peptides
|
|
CA2341754A1
(en)
*
|
1998-08-31 |
2000-03-09 |
New York University |
Stem cells bearing an fgf receptor on the cell surface
|
|
ES2308852T3
(es)
|
1998-11-04 |
2008-12-01 |
Serono Genetics Inst Sa |
Secuencias genomicas y completas de cdna de apm1 humano especifico para adipocitos y marcadores bialelicos de los mismos.
|
|
DE60041912D1
(de)
|
1999-02-10 |
2009-05-14 |
Serono Genetics Inst Sa |
Polymorphe marker des lsr-gens
|
|
US20050272652A1
(en)
|
1999-03-29 |
2005-12-08 |
Gault Victor A |
Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
|
|
IL132312A0
(en)
*
|
1999-09-05 |
2001-03-19 |
Yeda Res & Dev |
Use of leptin in inhibition of endothelial cell proliferation
|
|
US6989367B2
(en)
|
2000-01-14 |
2006-01-24 |
Genset S.A. |
OBG3 globular head and uses thereof
|
|
US6566332B2
(en)
|
2000-01-14 |
2003-05-20 |
Genset S.A. |
OBG3 globular head and uses thereof for decreasing body mass
|
|
US20020058617A1
(en)
|
2000-01-14 |
2002-05-16 |
Joachim Fruebis |
OBG3 globular head and uses thereof for decreasing body mass
|
|
US7338787B2
(en)
|
2000-01-14 |
2008-03-04 |
Serono Genetics Institute S.A. |
Nucleic acids encoding OBG3 globular head and uses thereof
|
|
US8076288B2
(en)
|
2004-02-11 |
2011-12-13 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides having glucose lowering activity
|
|
EP1718665B1
(en)
|
2004-02-11 |
2013-04-10 |
Amylin Pharmaceuticals, LLC |
Hybrid polypeptides with selectable properties
|
|
US8263545B2
(en)
|
2005-02-11 |
2012-09-11 |
Amylin Pharmaceuticals, Inc. |
GIP analog and hybrid polypeptides with selectable properties
|
|
BRPI0606992A2
(pt)
|
2005-02-11 |
2009-07-28 |
Amylin Pharmaceuticals Inc |
análogo e polipeptìdeos hìbridos de gip com propriedades selecionáveis
|
|
BRPI0614649A2
(pt)
|
2005-08-11 |
2011-04-12 |
Amylin Pharmaceuticals Inc |
polipeptìdeos hìbridos com propriedades selecionáveis
|
|
EP2330124B1
(en)
|
2005-08-11 |
2015-02-25 |
Amylin Pharmaceuticals, LLC |
Hybrid polypeptides with selectable properties
|
|
US8497240B2
(en)
|
2006-08-17 |
2013-07-30 |
Amylin Pharmaceuticals, Llc |
DPP-IV resistant GIP hybrid polypeptides with selectable properties
|
|
TW202417497A
(zh)
|
2015-10-12 |
2024-05-01 |
美商再生元醫藥公司 |
活化瘦素受體的抗原結合蛋白
|
|
US10550192B2
(en)
|
2016-11-08 |
2020-02-04 |
Regeneron Pharmaceuticals, Inc. |
Antigen-binding proteins that antagonize leptin receptor
|
|
WO2019126071A1
(en)
|
2017-12-18 |
2019-06-27 |
Regeneron Pharmaceuticals, Inc. |
Bispecific antigen binding molecules that bind leptin receptor and/or gp130, and methods of use thereof
|
|
DK3773713T3
(da)
|
2018-04-06 |
2025-08-18 |
Regeneron Pharma |
Leptinreceptoragonistantistof til anvendelse i forøgelse af knoglemasse hos et individ, der lider af metabolisk dysfunktion eller hypoleptinæmI
|
|
US20210228685A1
(en)
*
|
2018-07-24 |
2021-07-29 |
Bioreg Llc |
Improved weight loss therapy
|